| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 1e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |